Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | TAK-280 |
Synonyms | |
Therapy Description |
Limited information is currently available on TAK-280 (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TAK-280 | TAK 280|TAK280|MVC280|MVC-280|MVC 280 | Limited information is currently available on TAK-280 (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05220098 | Phase Ib/II | TAK-280 | First-in-Human Study of TAK-280 in Participants With Unresectable Locally Advanced or Metastatic Cancer | Recruiting | USA | ESP | CAN | AUS | 0 |